Literature DB >> 4140477

[Intracystic therapy of bleomycin for craniopharyngioma--effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin (author's transl)].

O Kubo, K Takakura, Y Miki, T Okino, K Kitamura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4140477

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


× No keyword cloud information.
  7 in total

Review 1.  Intracavitary therapeutic options in the management of cystic craniopharyngioma.

Authors:  Adrián Cáceres
Journal:  Childs Nerv Syst       Date:  2005-07-19       Impact factor: 1.475

Review 2.  Intracystic bleomycin for cystic craniopharyngiomas in children.

Authors:  Si Zhang; Yuan Fang; Bo Wen Cai; Jian Guo Xu; Chao You
Journal:  Cochrane Database Syst Rev       Date:  2016-07-14

3.  Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children.

Authors:  Hiroshi Takahashi; Fumio Yamaguchi; Akira Teramoto
Journal:  Childs Nerv Syst       Date:  2005-06-01       Impact factor: 1.475

Review 4.  Interstitial chemotherapy for brain tumors: review.

Authors:  T Tomita
Journal:  J Neurooncol       Date:  1991-02       Impact factor: 4.130

5.  Treatment of Cystic Craniopharyngiomas: An Update.

Authors:  Federico Bianchi; Alberto Benato; Luca Massimi
Journal:  Adv Tech Stand Neurosurg       Date:  2022

6.  Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas.

Authors:  D F Ierardi; M J S Fernandes; I R Silva; J Thomazini-Gouveia; N S Silva; P Dastoli; S R C Toledo; S Cavalheiro
Journal:  Childs Nerv Syst       Date:  2007-06-26       Impact factor: 1.475

7.  Intracystic therapies for cystic craniopharyngioma in childhood.

Authors:  Ute Bartels; Normand Laperriere; Eric Bouffet; James Drake
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-27       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.